IE35018L - Therapeutic agent - Google Patents

Therapeutic agent

Info

Publication number
IE35018L
IE35018L IE710329A IE32971A IE35018L IE 35018 L IE35018 L IE 35018L IE 710329 A IE710329 A IE 710329A IE 32971 A IE32971 A IE 32971A IE 35018 L IE35018 L IE 35018L
Authority
IE
Ireland
Prior art keywords
glycoside
sitosterol
pharmaceutically acceptable
therapeutic compositions
compositions
Prior art date
Application number
IE710329A
Other versions
IE35018B1 (en
Original Assignee
Liebeuberg Roelof Wilke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ZA701861A external-priority patent/ZA701861B/en
Application filed by Liebeuberg Roelof Wilke filed Critical Liebeuberg Roelof Wilke
Publication of IE35018L publication Critical patent/IE35018L/en
Publication of IE35018B1 publication Critical patent/IE35018B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

1298047 Therapeutic compositions R W LIEBENBERG 19 April 1971 [18 March 1970 14 Aug 1970] 24417/71 Heading A5B Therapeutic compositions, having anti-inflammatory, hormonal, reactivating, conditioning and diuretic activity useful in the treatment of arthritis, cholesterosis, arteriosclerosis, and urogenital. diseases due to pathological conditions of the prostate gland, bladder and urinary tract, comprise either a glycoside or glycoside ester of #-sitosterol and a pharmaceutically acceptable solid or emulsion carrier, or a suspension of a glycoside or glycoside ester of #-sitosterol in a pharmaceutically acceptable liquid carrier. The active component is preferably #-sitosterol-#-D-glucoside. The compositions may be administered orally or parenterally in the form of tablets, capsules or processed food. [GB1298047A]
IE329/71A 1970-03-18 1971-03-15 Therapeutic agent IE35018B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA701861A ZA701861B (en) 1970-03-18 1970-03-18 Therapeutic agent
ZA705627 1970-08-14

Publications (2)

Publication Number Publication Date
IE35018L true IE35018L (en) 1971-09-18
IE35018B1 IE35018B1 (en) 1975-10-15

Family

ID=27131005

Family Applications (1)

Application Number Title Priority Date Filing Date
IE329/71A IE35018B1 (en) 1970-03-18 1971-03-15 Therapeutic agent

Country Status (7)

Country Link
BE (1) BE764305A (en)
CA (1) CA973095A (en)
DE (1) DE2113215C2 (en)
FR (1) FR2085718B1 (en)
GB (1) GB1298047A (en)
IE (1) IE35018B1 (en)
IL (1) IL36438A (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA721855B (en) * 1972-03-17 1973-05-30 Liebenberg R W Extraction of sterolins from plant material
JPS5123254A (en) * 1974-08-14 1976-02-24 Nippon Shinyaku Co Ltd Suteriru beetaa dd gurukoshidono parumichinsanesuteruno seizohoho
GB1468473A (en) * 1974-08-14 1977-03-30 Nippon Shinyaku Co Ltd Method for the preparation of steryl beta-d-glucoside palmitates
JPS51118817A (en) * 1975-04-08 1976-10-19 Nippon Shinyaku Co Ltd A process for preparing absorbable steroid glycoside pharmaceutical
FR2312257A1 (en) * 1975-05-28 1976-12-24 Nippon Shinyaku Co Ltd Steryl beta-D-glucoside medicaments - with haemostatic, vascular-strengthening and anti-shock activity
DE2659466A1 (en) * 1976-12-30 1979-02-15 Roecar Holdings Nv STEROLINE AND THEIR USE
DE2759171A1 (en) * 1977-12-31 1979-07-12 Roecar Holdings Nv MEDICINAL PRODUCTS WITH EFFECT AS PROSTAGLANDIN SYNTHETASE INHIBITOR
US4254111A (en) * 1978-07-05 1981-03-03 Roecar Holdings (Netherlands Antilles) Nv Sterolin products
DE3401178A1 (en) * 1984-01-14 1985-07-18 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen USE OF PHYTOSTEROL GLYCOSIDES FOR TREATING INCREASED 5 (6) (ALPHA) EPOXICHOLESTEROL LEVELS
DE3416112A1 (en) * 1984-04-30 1985-10-31 Roecar Holdings (Netherlands Antilles) N.V., Willemstad, Curacao, Niederländische Antillen USE OF STEROLINES AND SPIROKETALINES AS LIPOXYGENAS REGULATORS
ATE142883T1 (en) * 1991-03-28 1996-10-15 Rooperol Na Nv COMPOSITIONS OF PHYTOSTEROLS WITH PHYTOSTEROLINS AS IMMUNE MODULATORS
US5998396A (en) * 1996-11-05 1999-12-07 Riken Vitamin Co., Ltd. Oil solubilized solutions and foods containing phytosterols and process for their production
FI974648A7 (en) 1997-09-09 1999-05-06 Raisio Benecol Oy Hydroxy acid, lactic acid and hydroxyalkanoate esters and their use
US6267963B1 (en) * 1999-06-02 2001-07-31 Kraft Foods, Inc. Plant sterol-emulsifier complexes
US6190720B1 (en) * 1999-06-15 2001-02-20 Opta Food Ingredients, Inc. Dispersible sterol compositions
CA2389670A1 (en) * 1999-11-01 2001-05-10 Forbes Medi-Tech Inc. Novel glycosides comprising pentose mono-, di-, tri-, or oligosaccharides and phytosterols and/or phytostanols

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1177645A (en) * 1966-06-10 1970-01-14 Lab Du Dr Debat Plant Extracts and Compositions Containing Same.
GB1248684A (en) * 1969-01-31 1971-10-06 Inst Rech S Chimiques Et Biolo Medicinal extracts of plants of the genus prunus and a method of obtaining them

Also Published As

Publication number Publication date
DE2113215C2 (en) 1985-03-21
DE2113215A1 (en) 1971-10-07
GB1298047A (en) 1972-11-29
BE764305A (en) 1971-08-16
CA973095A (en) 1975-08-19
IL36438A (en) 1974-11-29
FR2085718B1 (en) 1974-08-30
FR2085718A1 (en) 1971-12-31
IL36438A0 (en) 1971-05-26
IE35018B1 (en) 1975-10-15

Similar Documents

Publication Publication Date Title
IE35018L (en) Therapeutic agent
US4415554A (en) Treatment for menstrual disorders
EG19642A (en) A process for the preparation of oral composition for the treatment of inflammatory bowel diseases
US3324002A (en) Anti-inflammatory preparations containing proteolytic enzymes and adrenal glucocorticoids
GB1464388A (en) Preparations containing microencapsulated substances and process
Emmanuel et al. Gastric ulcer and the anti-arthritic drugs
GB1502873A (en) Pharmaceutical compositions with ulcer healing activity
GB1402691A (en) Composition of 4-biphenyl acetic acid
GB1287602A (en) 4,6-DICHLORO-Delta<4.6>-OESTRADIENES
GB1381426A (en) Method of treating mammals and composition comprising oligosaccha ride sulphuric acid esters and nonionic surface active agents
GB1388856A (en) Fibrinolytic activators comprising derivatives of phenyl benzoate
FI74003B (en) FREQUENCY REQUIREMENT FOR THE ADMINISTRATION OF THERAPEUTIC 5,14-DIHYDROBENS / 5,6 / ISOINDOLO / 2,1-B / ISOKINOLIN-8,13-DION.
Fuller et al. Confluent and reticulate papillomatosis of Gougerot and Carteaud clearing with minocycline
CA953294A (en) Preparation of 3'-4'-dideoxykanamycin b active against resistant bacteria
US4237117A (en) Method for the treatment of benign prostatic hypertrophy
US3715349A (en) 17-hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid gamma-lactone
GB1125924A (en) Organic bismuth derivative
GB1463260A (en) Pharmacologically active acetic acid derivative
GB1375806A (en)
IE35711L (en) Pharmaceutical compositions
GB1191180A (en) Therapeutic Composition
GB1269616A (en) Improvements in pharmaceutical compositions
IL43236A (en) 15alpha,16alpha-methylene-19-nor-delta4-pregnene-3,20-diones
FR2029415A1 (en) 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1
NL6902213A (en) 2-chloro-6alpha 9alpha-difluoro-16alpha-methylpregna-1